Sanofi SAN1.48%increase; green up pointing triangle shares fell after the drugmaker said Belen Garijo, the chief executive of Germany’s Merck MRK-1.76%decrease; red down pointing triangle KGaA, would ...

Portillo’s, the Chicago-based restaurant chain that has recently scaled back expansion plans amid sluggish sales, has a new CEO. Portillo's has tapped Brett Patterson as its new CEO. (Portillo's) ...

Sanofi has replaced its CEO Paul Hudson after a series of R&D setbacks at the French pharma, handing the reins to Merck KGaA leader Belén Garijo, M.D., Ph.D. Following the departure of GSK CEO Emma ...

When Michelle Eisen and her fellow baristas organized an upstart union at a Starbucks, she and others were frustrated by the messaging from the top. It was late 2021 and Starbucks’ then-CEO Kevin ...

Harry Sommer has left Norwegian Cruise Line Holdings. Photo Credit: NCLH Norwegian Cruise Line Holdings said Thursday that CEO Harry Sommer has stepped down, replaced by former Subway and Burger King ...

Anthropic CEO Dario Amodei says he’s not sure whether his Claude AI chatbot is conscious — a rhetorical framing, of course, that pointedly leaves the door open to this sensational and still-unlikely ...

Dubai's DP World announced Essa Kazim was the new chairman of its board of directors and Yuvraj Narayan was its new group chief executive officer, replacing Sultan Ahmed bin Sulayem. Sulayem had been ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. Sanofi is replacing Paul Hudson as CEO, the company announced Thursday, ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

French drugmaker Sanofi ousted CEO Paul Hudson on Thursday, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from U.S. anti-vaccine ...

Sanofi’s (SNY) board has decided not to renew the director mandate of Paul Hudson. Hudson joined Sanofi as CEO in September 2019. Previously, he served as CEO of Novartis Pharmaceuticals from 2016 to ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A successor has been named ...